Encision (Encision) Risk Assessment

View and export this data going back to 1996. Start your Free Trial

What is Encision Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Encision is: High Risk: High uncertainty with risk-return tradeoff.

Competitive Comparison of Encision's Risk Assessment

For the Medical Instruments & Supplies subindustry, Encision's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Encision's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Encision's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Encision's Risk Assessment falls into.

Encision (OTCPK:ECIA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Encision Risk Assessment Related Terms

Thank you for viewing the detailed overview of Encision's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Encision (Encision) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Encision Inc (OTCPK:ECIA) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

6797 Winchester Circle, Boulder, CO, USA, 80301

Website

https://www.encision.com

Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally-invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities.

Executives

Robert H Fries	director	800 FILLMORE ST, DENVER CO 80206
Peter D Geary	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Jason E Johnson	officer: VP Sales	17752 WEDGEWOOD LANE, PRIOR LAKE MN 55372
Patrick R Dixon	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Gregory J. Trudel	director, officer: CEO	5241 RIMROCK LANE, FORT COLLINS CO 80526
Brian J Jackman	director	6797 WINCHESTER CIRCLE, SUITE 100, BOULDER CO 80301
Von Der Lippe Paul	director	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Denise Baker	director	6797 WINCHESTER CIRCLE, BOULDER X1 80301
Vern D Kornelsen	director, 10 percent owner	4605 S. DENICE DR, ENGLEWOOD CO 80111
Partners Lllp Cmed	10 percent owner
Patrick W Pace	director	3701 SOARING EAGLE, AUSTIN TX 78746
Michael Biggs	officer: VP Engineering	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Brad Greathouse	officer: VP RA/QA	6797 WINCHESTER CIRCLE, BOULDER CO 80301
Valerie Ray	officer: VP of Operations	6797 WINCHESTER CIRCLE, BOULDER CO 80301
David W Newton	director, officer: VP Technology	8099 NORTH 63RD STREET, LONGMONT CO 80503